HeartWare International Inc (NASDAQ: HTWR), a developer of medical devices, confirmed on Wednesday it has received notice from Engaged Capital, an activist hedge fund and shareholder, which nominated ...

Recently, HeartWare International Inc. (HTWR) (HeartWare) disclosed the public offering of 1,500,000 of its common stock at $86.45 per share. This pricing came in accordance with the effective shelf ...

The struggles at Heartware International continue as the company saw continued year-over-year losses in the second quarter of 2016. Medtronic to buy Heartware for $1.1B Medtronic announced Monday that ...

Medtronic has agreed to pay a $54.5 million class-action settlement to investors to resolve allegations that a heart-pump company it acquired in 2016, HeartWare, repeatedly misled investors about the ...

Medical technology giant Medtronic plcMDT recently completed the acquisition of HeartWare International, Inc. HTWR - a global medical device manufacturer dedicated to serve patients with advanced ...

HeartWare International has agreed to acquire Valtech Cardio, and through that deal, the Framingham-based medical device firm sees a big opportunity to expand its reach in the structural heart market, ...

The FDA said today that it had granted approval to the HeartWare Ventricular Assist System for use in heart failure patients waiting for a transplant. Approval of the device had been expected after ...

The US Food and Drug Administration (FDA) is notifying physicians of a Class I recall of unimplanted HeartWare ventricular assist device (VAD) implant kits, initiated voluntarily by the company in ...

What: After updating investors on a key medical device in development and warning of a longer-than-hoped delay, shares in Heartware International (NASDAQ: HTWR) were down 33.8% at noon ET today. So ...

The FDA's Circulatory System Devices panel voted 9-2 on Wednesday to recommend approval of the HeartWare Ventricular Assist System as a bridge to heart transplantation for patients with end-stage ...

FRAMINGHAM, MA — The US Food and Drug Administration issued a formal warning to the makers of a recently approved ventricular assist device (VAD) system (HeartWare, Framingham, MA) for failing to take ...